Problem 9 - Clinical Chemistry

Question

A tumor marker used in the assessment of choriocarcinoma or hydatidiform mole is a. \(\beta-h C G\) b. CEA c. AFP d. \(\operatorname{IgG}\)

Step-by-Step Solution

Answer

a. \( \beta-h C G \)

Step 1: Understand the Question

Identify which tumor marker is used specifically for choriocarcinoma or hydatidiform mole from the given options.

Step 2: Recall Key Information

Choriocarcinoma and hydatidiform mole are related to pregnancy and produce high levels of the hormone human chorionic gonadotropin (hCG).

Step 3: Match the Options

Compare this information with the given options: a. \( \beta-h C G \) b. CEA c. AFP d. IgG

Step 4: Identify the Correct Option

Option a, \( \beta-h C G \), matches with human chorionic gonadotropin, the marker produced in high levels in these conditions. The other options (CEA, AFP, IgG) are markers for different conditions.

Key Concepts

choriocarcinoma

Choriocarcinoma is a rare and aggressive form of cancer that originates in the cells of the placenta—a structure that develops during pregnancy to provide oxygen and nutrients to the growing fetus. This type of cancer arises after a normal pregnancy, a molar pregnancy, a miscarriage, or an abortion. It is characterized by the abnormal growth of trophoblastic cells, which are responsible for the implantation of the embryo in the uterine wall. Choriocarcinoma can spread rapidly to other parts of the body, such as the lungs, liver, and brain.

This cancer often produces high levels of the hormone human chorionic gonadotropin (hCG), making hCG a valuable tumor marker for diagnosing and monitoring the disease. Early detection and treatment are crucial for improving outcomes, often involving a combination of chemotherapy and surgery. Regular monitoring of hCG levels can help track the effectiveness of treatment and detect any recurrence.

• Originates in placental cells
• Associated with high hCG levels
• Requires prompt treatment for better prognosis

hydatidiform mole

A hydatidiform mole, also known as a molar pregnancy, is a rare complication of pregnancy characterized by the abnormal growth of trophoblastic tissue—a form of tissue that normally becomes the placenta. There are two types of molar pregnancies: complete and partial.

In a complete molar pregnancy, the placental tissue is abnormal and swollen and appears to form fluid-filled cysts. No fetal tissue forms. In a partial molar pregnancy, there may be normal placental tissue along with abnormally forming placental tissue. Additionally, there may be a formation of a fetus, but it is not viable and often has severe defects.

Both types of molar pregnancies result in the overproduction of human chorionic gonadotropin (hCG), which is why hCG is used as a tumor marker for this condition. Treatment typically involves the surgical removal of the mole, followed by regular monitoring of hCG levels to ensure that the abnormal tissue has been completely removed and to check for any potential malignant transformation into choriocarcinoma.

• Abnormal growth of trophoblastic tissue
• Results in high levels of hCG
• Requires surgical removal and monitoring

human chorionic gonadotropin (hCG)

Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy by the cells of the placenta. It plays a crucial role in maintaining the corpus luteum, which in turn produces the hormone progesterone necessary to sustain the pregnancy.

hCG levels can be detected in the blood and urine of pregnant women and are often the basis for pregnancy tests. Beyond its role in pregnancy, hCG can also serve as a tumor marker, particularly in cases of trophoblastic diseases like choriocarcinoma and hydatidiform mole. Elevated levels of hCG in non-pregnant individuals can indicate the presence of these conditions.

Monitoring hCG levels is essential in diagnosing and treating these cancers. Treatments that effectively lower hCG levels often indicate successful therapy, while persistent levels may suggest the need for further medical intervention.

• Produced by placenta during pregnancy
• Maintains corpus luteum and progesterone production
• Serves as a tumor marker for certain cancers